Glenn J. Lesser, MD

Professor, Hematology and Oncology

Glenn J. Lesser, MD

Professor, Hematology and Oncology

About Me

Education: BA, Duke University, 1983; MD, Pennsylvania State University College of Medicine, 1987
Internship: Internal Medicine, North Carolina Baptist Hospital, 1998
Residency: Internal Medicine, North Carolina Baptist Hospital, 1991
Fellowship: Johns Hopkins University School, 1994
Memberships: Society of Neuro-Oncology; North Carolina Medical Association; Southern Association for Oncology; Southern Medical Association; American College of Physicians Fellow; American Medical Association; American Society of Clinical Oncology
Positions: Professor, Hematology and Oncology; Professor, Neurosurgery; Professor, Anesthesiology; Professor, Public Health Sciences
Departments and Affiliations: Hematology and Oncology; Neurosurgery; Anesthesiology; Public Health Sciences

Research

Publications
Clinical Trials

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A. JAMA Oncol. 2018 Oct; 4(10):1405-1409.
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?. Soike MH, McTyre ER, Shah N, Puchalski RB, Holmes JA, Paulsson AK, Miller LD, Cramer CK, Lesser GJ, Strowd RE, Hinson WH, Mott RT, Johnson AJ, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD. Neuroradiology. 2018 Oct; 60(10):1043-1051.
Hypoxia-inducible factor 2a: a novel target in gliomas. Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Future Med Chem. 2018 Sep; 10(18):2227-2236.
Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD. Am. J. Clin. Oncol. 2018 Aug; 41(8):813-819.
Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, Bryant D, Baglan K, Strasser J, Baez-Diaz L, Lesser GJ, Shaw EG. J. Clin. Oncol. 2018 Aug; 36(24):2473-2482.

View More Publications

More Resources

More Resources

Glenn J. Lesser, MD

Glenn J. Lesser, MD

About Me